Interleukin 2-Based Fusion Proteins for the Treatment of Cancer

Interleukin 2 (IL-2) plays a fundamental role in both immune activation and tolerance and has revolutionized the field of cancer immunotherapy since its discovery. The ability of IL-2 to mediate tumor regression in preclinical and clinical settings led to FDA approval for its use in the treatment of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alana MacDonald, T.-C. Wu, Chien-Fu Hung
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/fb172ce1ca654f948f000f3fe9370909
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!